Tocqueville Asset Management L.p. reports 1.49% decrease in ownership of EW / Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

MX ˙ BMV ˙ US28176E1082

Security	MX:EW / Edwards Lifesciences Corporation
Institution	Tocqueville Asset Management L.p.
Latest Disclosed Ownership	61,115 shares
Latest Disclosed Value	$ 4,894,089

On May 12, 2026 - Tocqueville Asset Management L.p. filed a 13F-HR form disclosing ownership of 61,115 shares of Edwards Lifesciences Corporation (MX:EW) valued at $4,894,089 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 62,040 shares of Edwards Lifesciences Corporation. This represents a change in shares of -1.49% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-12	2026-03-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	61,115	-925	-1.49	4,894	-7.45	0.0726
2026-02-12	2025-12-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	62,040	-150	-0.24	5,289	9.35	0.0771
2025-11-13	2025-09-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	62,190	-15,995	-20.46	4,837	-20.90	0.0703
2025-08-12	2025-06-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	78,185	-300	-0.38	6,115	7.49	0.0931
2025-05-13	2025-03-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	78,485	-4,085	-4.95	5,689	-6.94	0.0929
2025-02-10	2024-12-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	82,570	-1,215	-1.45	6,113	10.56	0.0959
2024-11-08	2024-09-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	83,785	-4,300	-4.88	5,529	-32.06	0.0868
2024-08-12	2024-06-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	88,085	-370	-0.42	8,136	-3.74	0.1343
2024-05-09	2024-03-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	88,455	-320	-0.36	8,453	24.86	0.1381
2024-02-12	2023-12-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	88,775	-135	-0.15	6,769	9.90	0.1227
2023-11-09	2023-09-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	88,910	-862	-0.96	6,160	-27.27	0.1170
2023-08-11	2023-06-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	89,772	0	0.00	8,468	14.03	0.1516
2023-05-10	2023-03-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	89,772	-80	-0.09	7,427	10.79	0.1403
2023-02-09	2022-12-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	89,852	-1,045	-1.15	6,704	-10.76	0.1273
2022-11-10	2022-09-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	90,897	-2,945	-3.14	7,511	-15.82	0.1531
2022-08-12	2022-06-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	93,842	-970	-1.02	8,923	-20.05	0.1632
2022-05-16	2022-03-31	13F	Edwards Lifesciences	COM	28176E108	94,812	-1,890	-1.95	11,161	-10.91	0.1686
2022-02-14	2021-12-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	96,702	-150	-0.15	12,528	14.25	0.1723
2021-11-15	2021-09-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	96,852	-2,730	-2.74	10,965	6.31	0.1624
2021-08-16	2021-06-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	99,582	-875	-0.87	10,314	22.76	0.1490
2021-05-17	2021-03-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	100,457	565	0.57	8,402	-7.80	0.1293
2021-02-16	2020-12-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	99,892	-918	-0.91	9,113	13.25	0.1521
2020-11-16	2020-09-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	100,810	-10,580	-9.50	8,047	4.53	0.1539
2020-08-12	2020-06-30	13F	EDWARDS LIFESCIENCES	COM	28176E108	111,390	73,690	195.46	7,698	8.25	0.1605
2020-05-15	2020-03-31	13F	EDWARDS LIFESCIENCES	COM	28176E108	37,700	-7,829	-17.20	7,111	-33.05	0.1767
2020-01-14	2019-12-31	13F	Edwards Lifesciences	COM	28176E108	45,529	330	0.73	10,621	6.85	0.1562
2019-10-31	2019-09-30	13F	Edwards Lifesciences	COM	28176E108	45,199	3,329	7.95	9,940	28.51	0.1349
2019-07-31	2019-06-30	13F	Edwards Lifesciences	COM	28176E108	41,870	-895	-2.09	7,735	-5.46	0.1002
2019-04-30	2019-03-31	13F	Edwards Lifesciences	COM	28176E108	42,765	-490	-1.13	8,182	23.50	0.1092
2019-02-08	2018-12-31	13F	Edwards Lifesciences	COM	28176E108	43,255	-175	-0.40	6,625	-12.38	0.0993
2018-11-13	2018-09-30	13F	Edwards Lifesciences	COM	28176E108	43,430	-365	-0.83	7,561	18.60	0.0953
2018-08-13	2018-06-30	13F	Edwards Lifesciences	COM	28176E108	43,795	-320	-0.73	6,375	3.57	0.0809
2018-05-14	2018-03-31	13F	Edwards Lifesciences	COM	28176E108	44,115	185	0.42	6,155	24.32	0.0784
2018-02-13	2017-12-31	13F	Edwards Lifesciences	COM	28176E108	43,930	-800	-1.79	4,951	1.27	0.0562
2017-10-30	2017-09-30	13F	Edwards Lifesciences	COM	28176E108	44,730	-5,559	-11.05	4,889	-17.78	0.0562
2017-08-04	2017-06-30	13F	Edwards Lifesciences	COM	28176E108	50,289	-540	-1.06	5,946	24.37	0.0713
2017-04-28	2017-03-31	13F	Edwards Lifesciences	COM	28176E108	50,829	-36,625	-41.88	4,781	-41.65	0.0583
2017-01-30	2016-12-31	13F	Edwards Lifesciences	COM	28176E108	87,454	-67,775	-43.66	8,194	-56.21	0.1048
2016-10-31	2016-09-30	13F	Edwards Lifesciences	COM	28176E108	155,229	63,810	69.80	18,714	105.26	0.2247
2016-08-15	2016-06-30	13F/A-1	Edwards Lifesciences	COM	28176E108	91,419	-1,025	-1.11	9,117	11.81	0.1086
2016-07-29	2016-06-30	13F	Edwards Lifesciences	COM	28176E108	91,419			9,117
2016-04-29	2016-03-31	13F	Edwards Lifesciences	COM	28176E108	92,444	2,277	2.53	8,154	14.51	0.1080
2016-01-29	2015-12-31	13F	Edwards Lifesciences	COM	28176E108	90,167	58,728	186.80	7,121	59.31	0.0965
2015-10-30	2015-09-30	13F	Edwards Lifesciences	COM	28176E108	31,439	-1,495	-4.54	4,470	-4.71	0.0598
2015-07-31	2015-06-30	13F	Edwards Lifesciences	COM	28176E108	32,934	-32	-0.10	4,691	-0.11	0.0552
2015-04-30	2015-03-31	13F	Edwards Lifesciences	COM	28176E108	32,966	32,966	0.00	4,696		0.0552
2015-01-30	2014-12-31	13F	Edwards Lifesciences	COM	28176E108	0	-29,719	-100.00	0	-100.00
2014-10-30	2014-09-30	13F	Edwards Lifesciences	COM	28176E108	29,719	2,627	9.70	3,036	30.52	0.0337
2014-09-18	2014-06-30	13F/A-1	Edwards Lifesciences	COM	28176E108	27,092	-730	-2.62	2,326	12.69	0.0226
2014-07-30	2014-06-30	13F	Edwards Lifesciences	COM	28176E108	27,092			2,326
2014-04-30	2014-03-31	13F	Edwards Lifesciences	COM	28176E108	27,822	200	0.72	2,064	13.66	0.0272
2014-01-30	2013-12-31	13F	Edwards Lifesciences	COM	28176E108	27,622	3,450	14.27	1,816	7.90	0.0244
2013-10-30	2013-09-30	13F	Edwards Lifesciences	COM	28176E108	24,172	24,172		1,683		0.0210

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.